Clinical Trials Browser

Bile Duct Neoplasms × trametinib × 1 year × Clear all

NCT05874414 2026-01-22

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

Phase 1/2 Recruiting

Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma